Should I buy or sell Braskem stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Braskem in the last year. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" BAK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BAK, but not buy additional shares or sell existing shares. View BAK analyst ratings or view top-rated stocks .

What is Braskem's stock price target for 2024?

5 brokers have issued 12 month price objectives for Braskem's shares. Their BAK share price targets range from $11.00 to $40.00. On average, they expect the company's share price to reach $25.50 in the next twelve months. This suggests a possible upside of 197.5% from the stock's current price. View analysts price targets for BAK or view top-rated stocks among Wall Street analysts .

How have BAK shares performed in 2024?

Braskem's stock was trading at $8.82 at the beginning of 2024. Since then, BAK stock has decreased by 2.8% and is now trading at $8.57. View the best growth stocks for 2024 here .

Are investors shorting Braskem?

Braskem saw a drop in short interest in the month of March. As of March 15th, there was short interest totaling 2,030,000 shares, a drop of 11.4% from the February 29th total of 2,290,000 shares. Based on an average trading volume of 1,080,000 shares, the short-interest ratio is presently 1.9 days. View Braskem's Short Interest .

When is Braskem's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our BAK earnings forecast .

How were Braskem's earnings last quarter?

Braskem S.A. (NYSE:BAK) posted its quarterly earnings results on Tuesday, March, 19th. The company reported ($0.80) earnings per share for the quarter, missing the consensus estimate of ($0.55) by $0.25. The company earned $3.37 billion during the quarter, compared to analyst estimates of $3.50 billion. Braskem had a negative trailing twelve-month return on equity of 77.04% and a negative net margin of 6.61%.

What is Roberto Lopes Pontes Simões' approval rating as Braskem's CEO?

31 employees have rated Braskem Chief Executive Officer Roberto Lopes Pontes Simões on Glassdoor.com . Roberto Lopes Pontes Simões has an approval rating of 100% among the company's employees. This puts Roberto Lopes Pontes Simões in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Braskem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Braskem investors own include Amarin (AMRN) , Enterprise Products Partners (EPD) , Micron Technology (MU) , Pfizer (PFE) , AT&T (T) , AbbVie (ABBV) , Aduro Biotech (ADRO) , Armata Pharmaceuticals (ARMP) , CRISPR Therapeutics (CRSP) and Chevron (CVX) .

How do I buy shares of Braskem?

Shares of BAK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NYSE:BAK

Braskem (BAK) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free BAK Stock Alerts

$8.59

-0.12 (-1.38%)

(As of 04/17/2024 ET)

Compare

Today's Range: $8.55
▼
$8.70
50-Day Range: $6.85
▼
$10.91
52-Week Range: $6.30
▼
$12.67

Volume: 727,607 shs
Average Volume: 1.01 million shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $25.50

Get Braskem alerts:

Braskem MarketRank™ Stock Analysis

Analyst Rating: Hold
2.20 Rating Score
Upside/Downside: 197.5% Upside
$25.50 Price Target
Short Interest: Healthy
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.99) to $0.55 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.93 out of 5 stars

3.1

Analyst's Opinion

Consensus Rating
Braskem has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 2 buy ratings, 2 hold ratings, and 1 sell rating.
Amount of Analyst Coverage
Braskem has received no research coverage in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
Short Interest Ratio / Days to Cover
Braskem has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Braskem has recently decreased by 4.43%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
Braskem does not currently pay a dividend.
Dividend Growth
Braskem does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for BAK.

1.1

News and Social Media Coverage

Search Interest
4 people have searched for BAK on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.
MarketBeat Follows
2 people have added Braskem to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Braskem insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 0.01% of the stock of Braskem is held by insiders.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Braskem are expected to grow in the coming year, from ($0.99) to $0.55 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Braskem is -3.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Braskem is -3.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Braskem has a P/B Ratio of 3.27. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Paradigm Press

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

About Braskem Stock (NYSE:BAK)

Braskem S.A., together with its subsidiaries, produces and sells thermoplastic resins. The company operates through three segments: Brazil, United States and Europe, and Mexico. The Brazil segment produces and sells olefins, including ethylene, polymer and chemical grade propylene, butadiene, and butene-1; benzene, toluene, and xylenes products; fuels, such as automotive gasoline, liquefied petroleum gas, ethyl tertiary-butyl ether, and methyl tertiary-butyl ether; intermediates, such as cumene; aliphatics, aromatics, and hydrogenated solvents; and specialties comprising isoprene, dicyclopentadiene, piperylene, nonene, tetramer, polyisobutylene, and hydrocarbon resins. This segment also produces and sells polyethylene (PE) and polypropylene (PP); supplies electricity and other inputs to second-generation producers; produces and sells of PE, including the production of green PE from renewable resources; and produces and sells polyvinyl chloride and caustic soda. The United States and Europe segment produces and sells PP in the United States and Germany. The Mexico segment produces and sells ethylene, high-density PE, and low-density PE in Mexico. It also manufactures, sells, imports, and exports chemicals, petrochemicals, and fules; produces, supplies, and sells utilities, such as steam, water, compressed air, and industrial gases; and provides industrial services. The company was formerly known as Copene Petroquímica do Nordeste S.A. and changed its name to Braskem S.A. in 2002. Braskem S.A. was founded in 1972 and is headquartered in Camaçari, Brazil.

BAK Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BAK Stock News Headlines

March 29, 2024 | seekingalpha.com

Drama At The Chemours Company Opens The Door For Upside

March 21, 2024 | seekingalpha.com

Braskem S.A. (BAK) Q4 2023 Earnings Call Transcript

April 17, 2024 | Paradigm Press (Ad)

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

March 19, 2024 | investorplace.com

BAK Stock Earnings: Braskem Misses EPS for Q4 2023

March 19, 2024 | benzinga.com

Recap: Braskem Q4 Earnings

March 19, 2024 | finanznachrichten.de

Braskem S.A.: Braskem posts Recurring EBITDA of US$211 million in the quarter, up 13% from 3Q23

March 19, 2024 | finance.yahoo.com

Braskem posts Recurring EBITDA of US$211 million in the quarter, up 13% from 3Q23

March 15, 2024 | br.investing.com

Calendário econômico: “Super Quarta” terá decisões de juros no Brasil e nos EUA

April 17, 2024 | Paradigm Press (Ad)

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

March 15, 2024 | msn.com

Ibovespa tem oscilação modesta com vencimento de opções e balanços no radar

March 14, 2024 | businesswire.com

Shell Chemicals and Braskem Bring Certified Bio-Attributed and Bio-Circular Propylene and Polypropylene to the U.S. Market

March 13, 2024 | msn.com

Braskem Donates $10,000 to Marcus Hook Library for STEM Education and Facility Improvements

March 8, 2024 | businesswire.com

Braskem Donates to the Mary M. Campbell Marcus Hook Public Library

February 26, 2024 | businesswire.com

Braskem Hosts 25th Red Cross Blood Drive in Partnership with the American Red Cross

February 20, 2024 | reuters.com

Brazil's Petrobras wants to share management of Braskem, says CEO

February 18, 2024 | msn.com

Este indicador aponta boas oportunidades em correções, diz analista; conheça

February 18, 2024 | br.investing.com

Ibovespa fecha em alta com Vale e Petrobras apesar de inflação elevada nos EUA

February 14, 2024 | finance.yahoo.com

Carlos Slim’s Backing Triggers Best Bond Rally in Latin America

January 25, 2024 | seekingalpha.com

Braskem: Mounting Troubles Impacting Financial Performance

January 5, 2024 | finance.yahoo.com

Braskem (BAK) Is Attractively Priced Despite Fast-paced Momentum

December 19, 2023 | reuters.com

Austria's RBI to take 28% stake in Strabag in effort to shed Russia exposure

December 17, 2023 | msn.com

Exclusive: ECB governors see no dovish pivot before March, cut before June - sources

December 16, 2023 | morningstar.com

Braskem SA ADR BAK

December 16, 2023 | msn.com

Bank of Italy cuts 2024 GDP forecast to 0.6%, sees inflation below 2%

December 13, 2023 | seekingalpha.com

Braskem: ESG Challenges Take Center Stage In The Investment Thesis

November 10, 2023 | finance.yahoo.com

Adnoc Makes New Offer to Buy Controlling Stake in Braskem

November 9, 2023 | prnewswire.com.br

Braskem registra EBITDA Recorrente de US$ 187 milhões no trimestre, 34% superior ao 2T23

See More Headlines

Receive BAK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Braskem and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/19/2024
Today: 4/17/2024
Next Earnings (Estimated): 5/14/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Oils/Energy
Industry: Industrial organic chemicals
Sub-Industry: N/A
Current Symbol: NYSE:BAK
CUSIP: N/A
CIK: 1071438
Web: www.braskem.com.br
Phone: 551135769735
Fax: 55-11-3576-9532
Employees: 8,668
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $25.50
High Stock Price Target: $40.00
Low Stock Price Target: $11.00
Potential Upside/Downside: +197.5%
Consensus Rating: Hold
Rating Score (0-4): 2.20
Research Coverage: 5 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($2.46)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-917,240,000.00
Net Margins: -6.61%
Pretax Margin: N/A
Return on Equity: -77.04%
Return on Assets: -5.18%

Debt

Debt-to-Equity Ratio: 12.28
Current Ratio: 1.54
Quick Ratio: 1.03

Sales & Book Value

Annual Sales: $14.14 billion
Price / Sales: N/A
Cash Flow: $0.27 per share
Price / Cash Flow: 32.13
Book Value: $2.62 per share
Price / Book: 3.27

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 1.96

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

Mr. Roberto Bischoff (Age 68)
Chief Executive Officer
Mr. Pedro van Langendonck Teixeira de Freitas (Age 49)
CFO and Head of Procurement & Institutional Relation
Mr. Daniel Sales Correa (Age 55)
Executive Officer and Head of Investments & Digital Technologies
Mr. Everson Bassinello
Chief Compliance Officer
Ms. Cristiana Lapa (Age 47)
General Counsel & Corporate Governance Officer
Mr. Marcelo Arantes De Carvalho (Age 56)
Executive Officer and Head of People, Communication, Marketing & Sustainable Development
Mr. Marcelo de Oliveira Cerqueira (Age 59)
Executive Officer and Head of Brazil Manufacturing & Global Industrial Operations
Mr. Edison Terra Filho (Age 52)
Executive Officer and Head of the Olefins & Polyolefins South America
Dr. Daniel P. MacEachran
Head of Metabolic Engineering
Mr. Flávio Rossini
Company Secretary

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

BAK Stock Analysis - Frequently Asked Questions

Should I buy or sell Braskem stock right now?: 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Braskem in the last year. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" BAK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BAK, but not buy additional shares or sell existing shares.
View BAK analyst ratings or view top-rated stocks.
What is Braskem's stock price target for 2024?: 5 brokers have issued 12 month price objectives for Braskem's shares. Their BAK share price targets range from $11.00 to $40.00. On average, they expect the company's share price to reach $25.50 in the next twelve months. This suggests a possible upside of 197.5% from the stock's current price.
View analysts price targets for BAK or view top-rated stocks among Wall Street analysts.
How have BAK shares performed in 2024?: Braskem's stock was trading at $8.82 at the beginning of 2024. Since then, BAK stock has decreased by 2.8% and is now trading at $8.57.
View the best growth stocks for 2024 here.
Are investors shorting Braskem?: Braskem saw a drop in short interest in the month of March. As of March 15th, there was short interest totaling 2,030,000 shares, a drop of 11.4% from the February 29th total of 2,290,000 shares. Based on an average trading volume of 1,080,000 shares, the short-interest ratio is presently 1.9 days.
View Braskem's Short Interest.
When is Braskem's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our BAK earnings forecast.

How were Braskem's earnings last quarter?: Braskem S.A. (NYSE:BAK) posted its quarterly earnings results on Tuesday, March, 19th. The company reported ($0.80) earnings per share for the quarter, missing the consensus estimate of ($0.55) by $0.25. The company earned $3.37 billion during the quarter, compared to analyst estimates of $3.50 billion. Braskem had a negative trailing twelve-month return on equity of 77.04% and a negative net margin of 6.61%.
What is Roberto Lopes Pontes Simões' approval rating as Braskem's CEO?: 31 employees have rated Braskem Chief Executive Officer Roberto Lopes Pontes Simões on Glassdoor.com. Roberto Lopes Pontes Simões has an approval rating of 100% among the company's employees. This puts Roberto Lopes Pontes Simões in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Braskem own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Braskem investors own include Amarin (AMRN), Enterprise Products Partners (EPD), Micron Technology (MU), Pfizer (PFE), AT&T (T), AbbVie (ABBV), Aduro Biotech (ADRO), Armata Pharmaceuticals (ARMP), CRISPR Therapeutics (CRSP) and Chevron (CVX).
How do I buy shares of Braskem?: Shares of BAK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:BAK) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Braskem (BAK) Stock Price, News & Analysis

Braskem MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Braskem Stock (NYSE:BAK)

BAK Stock Price History

BAK Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Institutional Ownership

BAK Stock Analysis - Frequently Asked Questions

Overall MarketRank^™